Back to Results
First PageMeta Content
Motor neurone disease / Amyotrophic lateral sclerosis / James Heywood / ALS Association / ALS Therapy Development Institute / Health / Rare diseases


Summit Brings Major Non-Profits, Venture, Pharma and Academics Together
Add to Reading List

Document Date: 2013-08-26 11:19:13

Open Document

File Size: 419,71 KB

Share Result on Facebook

City

Boston / Cranbury / Greenwich / CAMBRIDGE / Kenmore / /

Company

Novartis / Biogen Idec / Boston Business Journal / Third Rock Ventures / UCB Pharma / ALS TDI / to-BBB / /

Country

United States / /

Event

FDA Phase / /

Facility

About ALS Therapy Development Institute / Westin Copley Place Hotel / ALS Therapy Development Institute / /

IndustryTerm

healthcare / drug discovery tools / human induced pluripotent stem cell technology / /

MedicalCondition

progressive neurodegenerative disease / Lou Gehrig’s disease / ALS / amyotrophic lateral sclerosis / multiple sclerosis / paralysis / disease / disorders / /

Organization

RGK Foundation / Stanford University School of Medicine / MDA / ALS Therapy Development Institute / Cystic Fibrosis Foundation / /

Person

Rick Cochran / Weperen / Philip Reilly / Steve Finkbeiner / Kevin Swan / Julie Donnelly / Lou Gehrig / Amelie Gubitz / Jenny Dwyer / Mike Gold / Aaron Gitler / Roger Petrone Jr. / Robert Beall / Steve Perrin / Gladstone Institutes / Andy Rubenstein / /

Position

director / extramural research program / program director / VP clinical therapeutic area CNS / associate professor of genetics / CEO / professor / president and CEO / associate director and senior investigator / healthcare and life sciences reporter / /

Product

TDI-132 / /

ProvinceOrState

New Jersey / Connecticut / Washington / Massachusetts / /

PublishedMedium

the Boston Business Journal / /

Technology

human induced pluripotent stem cell technology / drug discovery / Drug Development / /

URL

www.als.net / www.als.net/summit / www.als.net/summit/awards / /

SocialTag